Search Results - "Erol, Atakan"

Ocular manifestations in hemodialysis patients and short‐term changes in ophthalmologic findings by Sariyeva Ismayılov, Ayna, Aydin Guclu, Ozge, Erol, Haşim Atakan

“…The purpose of this study was to investigate the frequency of ocular manifestations in hemodialysis (HD) patients and short‐term changes in ophthalmologic…”
Get full text

Do Alarmins Have a Role in Multiple Myeloma? by Gedük, Ayfer, Polat, Merve Gökçen, Terzi Demirsoy, Esra, Öztaş, Berrin, Eryılmaz, Baldan Huri, Yenihayat, Emel Merve, Albayrak, Hayrunnisa, Erol, Haşim Atakan, Mehtap, Özgür, Tarkun, Pınar, Hacıhanefioğlu, Abdullah

“…Calprotectin (CLP), S100A6, and high mobility group nucleosome-binding protein 1 (HMGN1), known as alarmins, are involved in the pathogenesis of many tumors…”
Get full text

Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye by Tekinalp, Atakan, Gedük, Ayfer, Akdeniz, Aydan, Terzi Demirsoy, Esra, Gürsoy, Vildan, Aslaner Ak, Müzeyyen, Bağcı, Metin, Seçilmiş, Sema, Keklik Karadağ, Fatma, Oruç Uysal, Ayşe, Doğan, Ali, Demircioğlu, Sinan, Erol, Haşim Atakan, Aslan, Ceyda, Özkalemkaş, Fahir, Ertop, Şehmus, Dağlı, Mehmet, Dal, Mehmet Sinan, Saydam, Güray, Merter, Mustafa, Ural, Cihan, Çeneli, Özcan

“…This study aimed to evaluate patients with relapsed/refractory multiple myeloma (RRMM) who underwent daratumumab (DARA) therapy. This multicenter retrospective…”
Get full text

PB1957: PROGNOSTIC SIGNIFICANCE OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH IGHV‐U IN THE ERA OF NOVEL AGNETS; REAL‐LİFE DATA by Arikan, Fatma, Ata, Pinar, Demir, Senol, Yildirim, Ozlem, Mehtap, Özgür, Erol, Atakan, Orhan, Bedrettin, Ozkalemkas, Fahir, Menguc, Meral Ulukoylu, Demirtas, Derya, Yanik, Ahmet Mert, Candan, Ozlem, Toptas, Tayfur, Tuglular, Ayse Tulin

Get full text

Correction to: Efects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma by Geduk, Ayfer, Oztas, Berrin, Eryılmaz, Baldan Huri, Demirsoy, Esra Terzi, Menguc, Meral U., Unal, Serkan, Mersin, Sinan, Polat, Merve Gokcen, Aygun, Kemal, Yenihayat, Emel Merve, Albayrak, Hayrunnisa, Erol, Hasim Atakan, Balcı, Sibel, Mehtap, Ozgur, Tarkun, Pinar, Hacihanefioglu, Abdullah

“…[This corrects the article DOI: 10.1007/s12288-022-01574-6.]…”
Get full text

Effects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma by Geduk¹, Ayfer, Oztas, Berrin, Eryılmaz, Baldan Huri, Demirsoy, Esra Terzi, Menguc, Meral U., Unal, Serkan, Mersin, Sinan, Polat, Merve Gokcen, Aygun, Kemal, Yenihayat, Emel Merve, Albayrak, Hayrunnisa, Erol, Hasim Atakan, Balcı, Sibel, Mehtap¹, Ozgur, Tarkun¹, Pinar, Hacihanefioglu¹, Abdullah

“…Purpose The receptor for advanced glycation end products (RAGE) upregulated during the onset and progression of cancer and bone-related pathologies. In this…”
Get full text

A Pilot Study for IgE as a Prognostic Biomarker in COVID-19 by Aydin Guclu, Ozge, Goktas, Seda Sezen, Gorek Dilektasli, Asli, Acet Ozturk, Nilufer Aylin, Demirdogen, Ezgi, Coskun, Funda, Ediger, Dane, Ursavas, Ahmet, Uzaslan, Esra, Erol, Hasim Atakan, Karacay, Nurdan Derya, Kaya Sel, Umut, Karadag, Mehmet

“…Laboratory biomarkers to estimate the severity of COVID-19 are crucial during the pandemic, since resource allocation must be carefully planned. In the present…”
Get full text